Your search for

3 results were returned

  1. Twobirds news
    01 June 2020
    Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB
    www.twobirds.com/en/news/press-releases/2020/czech-republic/bird-and-bird-law-firm-advised-indian-vaccine-manufacturer-serum-institute-of-india-pvt-ltd

    Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB, subsidiary of Novavax Inc, US ...

  2. Twobirds news
    13 May 2021
    Life Sciences team scoops seven LMG Life Sciences Europe Awards
    www.twobirds.com/en/news/press-releases/2021/global/life-sciences-team-scoops-seven-lmg-life-sciences-europe-awards

    Congratulations to our Life Sciences and Healthcare team who were recently presented with seven accolades at the LMG Life Sciences Europe Awards 2021, announced 13th May.

  3. Twobirds news
    30 May 2019
    International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera
    www.twobirds.com/en/news/press-releases/2019/uk/international-team-advises-chiesi-farmaceutici-on-inlicence-of-raxone-from-santhera

    International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")